Hereditary haemochromatosis IVD, kit, nucleic acid technique (NAT) - UK MHRA Medical Device Registration

Hereditary haemochromatosis IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 163410. The device is manufactured by ViennaLab Diagnostics GmbH from Austria, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Oxford Biosystems Ltd.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

MHRA Registered

In Vitro Diagnostic Device

🇬🇧

Hereditary haemochromatosis IVD, kit, nucleic acid technique (NAT)

MHRA Device ID: 163410•Ref: 163410

Device Type

In Vitro Diagnostic Device

Devices

Hereditary haemochromatosis IVD, kit, nucleic acid technique (NAT)

Type

IVD General

Date Registered

Nov 26, 2024

Last Updated

Mar 6, 2024

Manufacturer Information

Name

ViennaLab Diagnostics GmbH

Address

Gaudenzdorfer Guertel 43-45

Vienna, Austria

Created Date

Jul 8, 2022

Authorized Representative

Name

Oxford Biosystems Ltd

Relationship Type

UK Responsible Person

Address

184B Park Drive Milton Park Abingdon

Abingdon, Oxfordshire, United Kingdom

Postcode: OX14 4SE

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Other Products from ViennaLab Diagnostics GmbH (10)

Other Products from Same Authorized Representative (10)

Hereditary haemochromatosis IVD, kit, nucleic acid technique (NAT) - UK MHRA Medical Device Registration

Device Type

Devices

Type

Date Registered

Last Updated

Name

Address

Created Date

Name

Relationship Type

Address

DJ Fang

Alpha-fetoprotein (AFP) IVD, kit, fluorescent immunoassay

Cyclic citrullinated peptide antibody (anti-CCP) IVD, kit, fluorescent immunoassay

Streptococcus pneumoniae antigen IVD, kit, rapid ICT, clinical

Allergen-specific/total immunoglobulin E (IgE) antibody IVD, kit, fluorescent immunoassay

C-reactive protein (CRP) IVD, kit, fluorescent immunoassay

Cryptosporidium species antigen IVD, kit, rapid ICT, clinical

Respiratory syncytial virus (RSV) antigen IVD, kit, rapid ICT, clinical

SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing

Trichomonas vaginalis antigen IVD, kit, rapid ICT, clinical

D-dimer IVD, kit, fluorescent immunoassay

Coagulation factor XII mutation IVD, kit, nucleic acid technique (NAT)

Cytochrome P450 (CYP450) gene polymorphism IVD, kit, nucleic acid technique (NAT)

HLA class I antigen nucleic acid tissue typing IVD, kit, nucleic acid technique (NAT)

Coagulation factor XIII mutation IVD, kit, nucleic acid technique (NAT)

Alpha-1-antitrypsin deficiency IVD, kit, nucleic acid technique (NAT)

Fructose/lactose intolerance IVD, kit, nucleic acid technique (NAT)

Epidermal growth factor receptor (EGFR) gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)

KRAS gene mutation IVD, kit, nucleic acid technique (NAT)

BRAF V600 gene mutation IVD, kit, nucleic acid technique (NAT)

NRAS gene mutation IVD, kit, nucleic acid technique (NAT)

Insulin-like growth factor I (IGF1) IVD, kit, radioimmunoassay

Bordetella pertussis immunoglobulin M (IgM) antibody IVD, kit, enzyme immunoassay (EIA)

Borrelia afzelii immunoglobulin M (IgM) antibody IVD, kit, enzyme immunoassay (EIA)

Beta-2-microglobulin IVD, reagent

Beta-haemolytic Group A Streptococcus streptolysin O antibody IVD, calibrator

Beta-haemolytic Group A Streptococcus streptolysin O antibody IVD, reagent

C-reactive protein (CRP) IVD, control

Coagulation factor XIII IVD, calibrator

Cystatin C IVD, calibrator

Cystatin C IVD, control